Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 5 (May)

1. Malignant melanoma in early Parkinson's disease: the DATATOP trial.
   Mov Disord, 22(5): 720-2. [Abstract] [Full-text]
2. Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis.
   Genes Chromosomes Cancer, 46(7): 661-9. [Abstract] [Full-text]
3. Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.
   Clin Cancer Res, 13(9): 2745-50. [Abstract] [Full-text]
4. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
   Clin Cancer Res, 13(9): 2658-66. [Abstract] [Full-text]
5. T-cell distribution and adhesion receptor expression in metastatic melanoma.
   Clin Cancer Res, 13(9): 2549-56. [Abstract] [Full-text]
6. Basal cell carcinoma: treatment with imiquimod.
   Int J Dermatol, 46(5): 539-42. [Abstract] [Full-text]
7. Sister Mary Joseph's nodule as a metastasis of gallbladder carcinoma.
   Int J Dermatol, 46(5): 505-7. [Abstract] [Full-text]
8. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments.
   Int J Dermatol, 46(5): 453-9. [Abstract] [Full-text]
9. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
   Hum Gene Ther, 18(4): 379-86. [Abstract] [Full-text]
10. Therapeutic effect of pEgr-IL18-B7.2 gene radiotherapy in B16 melanoma-bearing mice.
    Hum Gene Ther, 18(4): 323-32. [Abstract] [Full-text]
11. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
    Cancer, 109(10): 1965-71. [Abstract] [Full-text]
12. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?
    Expert Opin Biol Ther, 7(5): 577-86. [Abstract] [Full-text]
13. A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation.
    Cancer Res, 67(9): 4264-70. [Abstract] [Full-text]
14. CD34 expression by hair follicle stem cells is required for skin tumor development in mice.
    Cancer Res, 67(9): 4173-81. [Abstract] [Full-text]
15. Metastatic melanoma to the kidney presenting with renal vein tumor thrombus.
    Urology, 69(5): 982.e7-9. [Abstract] [Full-text]
16. Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas.
    Genes Chromosomes Cancer, 46(6): 559-63. [Abstract] [Full-text]
17. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants.
    Hum Mutat, 28(6): 578-88. [Abstract] [Full-text]
18. Expression of GAGE family proteins in malignant melanoma.
    Cancer Lett, 251(2): 258-67. [Abstract] [Full-text]
19. Diagnosis and treatment of swellings in the hand.
    Postgrad Med J, 83(979): 296-300. [Abstract] [Full-text]
20. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients.
    Histopathology, 50(6): 764-72. [Abstract] [Full-text]
21. Novel inhibitors in the treatment of metastatic melanoma.
    Expert Rev Anticancer Ther, 7(5): 715-24. [Abstract] [Full-text]
22. Melanocytic "ball-in-mitts" and "microalveolar structures" and their role in the development of cellular blue nevi.
    Ann Diagn Pathol, 11(3): 160-75. [Abstract] [Full-text]
23. Superficial primitive neuroectodermal tumor/Ewing sarcoma (PN/ES): same tumor as deep PN/ES or new entity?
    Ann Diagn Pathol, 11(3): 153-9. [Abstract] [Full-text]
24. Reduced pSmad2 immunodetection correlates with increased primary melanoma thickness.
    Melanoma Res, 17(2): 131-6. [Abstract] [Full-text]
25. The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy.
    Melanoma Res, 17(2): 129-30. [Abstract] [Full-text]
26. Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
    Melanoma Res, 17(2): 117-27. [Abstract] [Full-text]
27. Molecular genetic analysis of NBS1 in German melanoma patients.
    Melanoma Res, 17(2): 109-16. [Abstract] [Full-text]
28. The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients.
    Melanoma Res, 17(2): 105-8. [Abstract] [Full-text]
29. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Melanoma Res, 17(2): 83-9. [Abstract] [Full-text]
30. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Melanoma Res, 17(2): 75-82. [Abstract] [Full-text]
31. Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favor of a benign process: a study from the French Sarcoma Group.
    Cancer, 109(8): 1584-98. [Abstract] [Full-text]
32. Pulmonary manifestations in patients with cutaneous T-cell lymphomas.
    Cancer, 109(8): 1550-5. [Abstract] [Full-text]
33. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.
    Cancer, 109(8): 1570-8. [Abstract] [Full-text]
34. Influence of age on survival in childhood spitzoid melanomas.
    Cancer, 109(8): 1579-83. [Abstract] [Full-text]
35. Use of chemical ablation with trichloroacetic acid to treat eyelid apocrine hidrocystomas in a cat.
    J Am Vet Med Assoc, 230(8): 1170-3. [Abstract] [Full-text]
36. Sun-protective behaviors in families at increased risk of melanoma.
    J Invest Dermatol, 127(6): 1343-50. [Abstract] [Full-text]
37. Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi.
    J Invest Dermatol, 127(6): 1468-70. [Abstract] [Full-text]
38. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.
    J Invest Dermatol, 127(6): 1351-7. [Abstract] [Full-text]
39. In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinoma.
    J Invest Dermatol, 127(6): 1516-23. [Abstract] [Full-text]
40. Novel CDKN2A mutations detected in western Swedish families with hereditary malignant melanoma.
    J Invest Dermatol, 127(6): 1465-7. [Abstract] [Full-text]
41. Association of hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) and malignant melanoma in two patients.
    Melanoma Res, 17(3): 201-3. [Abstract] [Full-text]
42. Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents.
    Melanoma Res, 17(3): 193-200. [Abstract] [Full-text]
43. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
    Melanoma Res, 17(3): 185-91. [Abstract] [Full-text]
44. Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up.
    Melanoma Res, 17(3): 177-83. [Abstract] [Full-text]
45. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Melanoma Res, 17(3): 147-54. [Abstract] [Full-text]
46. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Melanoma Res, 17(3): 139-45. [Abstract] [Full-text]
47. Metastatic angiosarcoma of the scalp causing Kasabach-Merritt syndrome.
    Am J Med Sci, 333(5): 293-5. [Abstract] [Full-text]
48. Cutaneous lupus erythematosus simulating squamous neoplasia: the clinicopathologic conundrum and histopathologic pitfalls.
    J Am Acad Dermatol, 56(6): 1013-20. [Abstract] [Full-text]
49. Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004).
    J Am Vet Med Assoc, 230(10): 1506-13. [Abstract] [Full-text]
50. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans.
    Mod Pathol, 20(6): 668-75. [Abstract] [Full-text]
51. Reproductive history and cutaneous malignant melanoma: a comparison between women and men.
    Am J Epidemiol, 165(11): 1265-70. [Abstract] [Full-text]
52. Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation.
    Cancer Res, 67(10): 4751-8. [Abstract] [Full-text]
53. Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage.
    Cancer Res, 67(10): 4648-56. [Abstract] [Full-text]
54. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
    J Urol, 177(6): 2074-9; discussion 2079-80. [Abstract] [Full-text]
55. Confident complete excision of lid-margin BCCs using a marginal strip: an alternative to Mohs' surgery.
    Br J Ophthalmol, 91(6): 794-6. [Abstract] [Full-text]
56. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
    J Clin Oncol, 25(15): 2078-85. [Abstract] [Full-text]
57. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.
    J Clin Oncol, 25(15): 1974-8. [Abstract] [Full-text]
58. Melanoma genomics reveals signatures of sensitivity to bio- and targeted therapies.
    Cell Immunol, 244(2): 154-7. [Abstract] [Full-text]
59. Confirmation of a BRAF mutation-associated gene expression signature in melanoma.
    Pigment Cell Res, 20(3): 216-21. [Abstract] [Full-text]
60. Melanoma invasion - current knowledge and future directions.
    Pigment Cell Res, 20(3): 161-72. [Abstract] [Full-text]
61. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Arch Otolaryngol Head Neck Surg, 133(5): 442-7. [Abstract] [Full-text]
62. Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years.
    Clin Oral Investig, 11(2): 165-9. [Abstract] [Full-text]
63. A surreptitious sinister sarcoma.
    Am J Dermatopathol, 29(3): 311-2; discussion 313. [Abstract] [Full-text]
64. Zosteriform connective tissue nevus: a case report.
    Am J Dermatopathol, 29(3): 303-5. [Abstract] [Full-text]
65. Epidermotropic metastatic prostate carcinoma presenting as an umbilical nodule-Sister Mary Joseph nodule.
    Am J Dermatopathol, 29(3): 290-2. [Abstract] [Full-text]
66. Giant pilomatricoma.
    Am J Dermatopathol, 29(3): 286-9. [Abstract] [Full-text]
67. Oculocutaneous oncocytic tumors: clinicopathologic and immunohistochemical study of 2 cases with literature review.
    Am J Dermatopathol, 29(3): 279-85. [Abstract] [Full-text]
68. Facial apocrine fibroadenoma in man: a rare finding.
    Am J Dermatopathol, 29(3): 274-8. [Abstract] [Full-text]
69. Primary cutaneous metaplastic carcinoma: report of a case involving angiosarcoma.
    Am J Dermatopathol, 29(3): 270-3. [Abstract] [Full-text]
70. Incidental granular parakeratotic cornification in carcinomas.
    Am J Dermatopathol, 29(3): 264-9. [Abstract] [Full-text]
71. Tubular adenoma and syringocystadenoma papilliferum: a reappraisal of their relationship. An interobserver study of a series, by a panel of dermatopathologists.
    Am J Dermatopathol, 29(3): 256-63. [Abstract] [Full-text]
72. Merkel cell-poor trichoblastoma with basal cell carcinoma-like foci.
    Am J Dermatopathol, 29(3): 249-55. [Abstract] [Full-text]
73. Sebaceous carcinoma arising in nevus sebaceus of Jadassohn: a clinicopathological study of five cases.
    Am J Dermatopathol, 29(3): 242-8. [Abstract] [Full-text]
74. Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.
    Am J Dermatopathol, 29(3): 237-41. [Abstract] [Full-text]
75. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Am J Dermatopathol, 29(3): 231-6. [Abstract] [Full-text]
76. Lessons learned from DNA repair defective syndromes.
    Exp Dermatol, 16(6): 532-44. [Abstract] [Full-text]
77. Squamous cell carcinoma induced by ultraviolet radiation originates from cells of the hair follicle in mice.
    Exp Dermatol, 16(6): 485-9. [Abstract] [Full-text]
78. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Exp Dermatol, 16(6): 465-7. [Abstract] [Full-text]
79. Metastatic myxoid melanoma with partial regression of the primary lesion.
    J Cutan Pathol, 34(6): 508-12. [Abstract] [Full-text]
80. Ductal eccrine carcinoma with squamous differentiation: apropos a case.
    J Cutan Pathol, 34(6): 503-7. [Abstract] [Full-text]
81. Mucinous hidradenoma: a report of three cases.
    J Cutan Pathol, 34(6): 497-502. [Abstract] [Full-text]
82. Plaque form of warty dyskeratoma - acantholytic dyskeratotic acanthoma.
    J Cutan Pathol, 34(6): 494-6. [Abstract] [Full-text]
83. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
    J Cutan Pathol, 34(6): 474-80. [Abstract] [Full-text]
84. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    J Cutan Pathol, 34(6): 467-73. [Abstract] [Full-text]
85. The expression of CD23 and CD40 in primary cutaneous B-cell lymphomas.
    J Cutan Pathol, 34(6): 461-6. [Abstract] [Full-text]
86. Cell adhesion protein expression in melanocytic matricoma.
    J Cutan Pathol, 34(6): 456-60. [Abstract] [Full-text]
87. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    J Cutan Pathol, 34(6): 448-55. [Abstract] [Full-text]
88. Breast, colorectal, and skin cancer screening practices and family history of cancer in U.S. women.
    J Womens Health (Larchmt), 16(4): 526-34. [Abstract] [Full-text]
89. Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma.
    Cancer, 109(9): 1799-803. [Abstract] [Full-text]
90. Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.
    Blood, 109(11): 4655-62. [Abstract] [Full-text]
91. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken.
    Int J Cancer, 121(2): 323-8. [Abstract] [Full-text]
92. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
    Appl Immunohistochem Mol Morphol, 15(2): 229-35. [Abstract] [Full-text]
93. Metallothionein immunolocalization in actinic skin nonmelanoma carcinomas.
    Appl Immunohistochem Mol Morphol, 15(2): 165-9. [Abstract] [Full-text]
94. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
    Photodermatol Photoimmunol Photomed, 23(2): 95-7. [Abstract] [Full-text]
95. Genetic factors associated with skin cancer in renal transplant patients.
    Photodermatol Photoimmunol Photomed, 23(2): 62-7. [Abstract] [Full-text]
96. Oral administration of (11E)-13-oxo-15,16-dinorlabda-8(20),11-dien-19-oic acid strongly reduces photocarcinogenesis in mouse skin exposed to UV-B irradiation.
    Chem Biodivers, 4(5): 1003-7. [Abstract] [Full-text]
97. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds.
    Mol Carcinog, 46(6): 453-65. [Abstract] [Full-text]
98. Melanoma incidence and mortality in Scotland 1979-2003.
    Br J Cancer, 96(11): 1772-7. [Abstract] [Full-text]
99. Mongolian spots with involvement of mandibular area.
    J Dermatol, 34(6): 381-4. [Abstract] [Full-text]
100. Collision tumour of trichofolliculoma and basal cell carcinoma.
     Australas J Dermatol, 48(2): 127-9. [Abstract] [Full-text]
101. Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.
     PLoS Med, 4(5): e176. [Abstract] [Full-text]
102. Cryosurgical treatment of lentigo maligna.
     J Dtsch Dermatol Ges, 5(6): 477-80. [Abstract] [Full-text]
103. A potential predictive marker for response to interferon in malignant melanoma.
     J Dtsch Dermatol Ges, 5(6): 456-9. [Abstract] [Full-text]
104. Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients.
     Int J Cancer, 121(3): 689-93. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.